Market revenue in 2022 | USD 65.6 million |
Market revenue in 2030 | USD 231.8 million |
Growth rate | 17.1% (CAGR from 2022 to 2030) |
Largest segment | Solid-phase synthesis |
Fastest growing segment | PCR-based Enzyme Synthesis |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Solid-phase Synthesis, Chip-based Synthesis, PCR-based Enzyme Synthesis |
Key market players worldwide | Genscript Biotech Corp Class H, Brooks Automation, Twist Bioscience Corp, ProteoGenix, Biomatik Corporation, Thermo Fisher Scientific Inc, Integrated DNA Technologies, Origene Technologies |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to gene synthesis market will help companies and investors design strategic landscapes.
Solid-phase synthesis was the largest segment with a revenue share of 36.13% in 2022. Horizon Databook has segmented the India gene synthesis market based on solid-phase synthesis, chip-based synthesis, pcr-based enzyme synthesis covering the revenue growth of each sub-segment from 2018 to 2030.
India possesses high growth potential in the gene synthesis market, owing to key market players introducing innovative products as well as undertaking various strategic initiatives for market expansion. For instance, in May 2020, Codex and Premas Life Sciences (PLS) introduced an automated gene synthesis platform in India.
The companies have signed a new sales distribution agreement for the distribution of Codex’s BioXP 3200 Platform in India. This fully automated platform can synthesize up to 32 libraries, genes, and clones in a single run.
A strong biotechnology base generates great opportunities for expansion of the gene synthesis market. India is among the top 12 destinations for biotechnology globally. The biotechnology industry includes more than 2,700 start-ups and more than 2,500 biotech organizations.
Horizon Databook provides a detailed overview of country-level data and insights on the India gene synthesis market, including forecasts for subscribers. This country databook contains high-level insights into India gene synthesis market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account